Literature DB >> 2409393

Platelets, platelet-derived growth factor, growth control, and their interactions with the vascular wall.

R Ross.   

Abstract

The response-to-injury hypothesis of atherosclerosis describes how risk factors associated with atherogenesis may alter endothelial function, creating opportunities for endothelial cell separation and interactions with blood monocyte/macrophages and platelets that result in the intimal proliferative smooth-muscle lesions of atherosclerosis. Growth factors derived from platelets (platelet-derived growth factor) and macrophages (macrophage-derived growth factor) are described and their possible role in atherogenesis is presented. Possible approaches for the prevention of atherosclerosis include the development of means of interfering with the activity of these growth factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409393     DOI: 10.1097/00005344-198500073-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

2.  Preliminary investigations on the effects of a Strongylus vulgaris larval extract, mononuclear factors and platelet factors on equine smooth muscle cells in vitro.

Authors:  S J Morgan; R W Storts; P C Stromberg; B A Sowa; J C Lay
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

3.  Modulation of DNA synthesis in aortic smooth muscle cells by dinitrotoluenes.

Authors:  K S Ramos; K K McMahon; C Alipui; D Demick
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

4.  Modulation of monocyte-endothelial cell interactions by platelet microparticles.

Authors:  O P Barry; D Praticò; R C Savani; G A FitzGerald
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 5.  Biomimetic nanoparticles for inflammation targeting.

Authors:  Kai Jin; Zimiao Luo; Bo Zhang; Zhiqing Pang
Journal:  Acta Pharm Sin B       Date:  2017-12-24       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.